Home » Business, Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech » Hemophilia A Drugs Market Worth 6.25% By 2019: Radiant Insights, Inc.
“Radiant Insights”
RadiantInsights.com includes new market research report on “Global Hemophilia A Drugs Market Size, Share And Trends Report Up To 2019: Radiant Insights” to its huge collection of research reports.

About hemophilia A

Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of this disorder.

Read Complete Report With TOC at:

Covered in this report

The report covers the current scenario and the growth prospects of the global hemophilia A drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment and prevention of hemophilia A. In this report, the market is also segmented based on the type of therapy.

The report covers APAC, Europe, and Americas; it also covers the landscape of the global hemophilia A drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key region

  • Americas
  • APAC
  • Europe

Key vendors

  • Baxter International
  • Bayer’s
  • CSL Behring
  • Novo Nordisk
  • Pfizer

Browse All Reports of This Category at:

Other prominent vendros

  • Alnylam Pharmaceuticals
  • Amarna Therapeutics
  • Asklepios
  • Biogen Idec
  • Catalyst Biosciences
  • Dimension Therapeutics
  • Dong-A Socio
  • Emergent BioSolutions
  • Grifols
  • Inspiration Biopharmaceuticals
  • Kedrion Biopharma
  • Octapharma
  • OPKO Health
  • rEVO Biologics
  • Sangamo BioSciences
  • Spark Therapeutics
  • UniQure 

Latest Report by Radiant Insights:

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit http://www.radiantinsights.com/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/global-hemophilia-a-market-2015-2019

Comments are closed.